The increasing ability to harness cannabidiol, a derivative of cannabis, to treat medical problems is due to the body’s endocannabinoid system (ECS).
This system, discovered by scientists at the Hebrew University of Jerusalem, is a set of natural pathways in our brain and body which carry messages to various regions to manage and regulate pain, appetite, mood regulation, and memory.
Israel Cancer Research Fund approved grants to the Hebrew University, and other Israeli institutions, for studies in blood, brain, breast, colorectal and many other types of cancers.
Prof. Yinon Ben-Neriah, of Hebrew University’s Faculty of Medicine, and 2019 EMET laureate, will be able to pursue further groundbreaking work on chronic myelogenous leukemia, due to this grant.
Porsche, the luxury car company, has decided to invest $2 million in the Israeli startup TriEye.
TriEye is a company that uses SWIR (short-wave-infrared) technology to allow autonomous vehicles to operate effectively even under challenging weather conditions.
The technology was developed in the Hebrew University’s Center for Nanoscience and Nanotechnology.
The Glocal MA program at The Hebrew University is helping making a difference on the ground.
Together with organizations like Tevel b’Tzedek, HU international students and young Israeli backpackers work in impoverished villages across South-East Asia to improve their residents’ nutrition, provide clean water, and create basic decent human living conditions for housing, health and education.
The Hebrew University of JerusalemDivision for Advancement and External RelationsMount Scopus 91905Jerusalem, IsraelTelephone: +972-2-588-2804
> Hebrew University Main Website
> Hebrew University Alumni Association
> Rothberg International School
> Hebrew University International Office
> Israeli Friends of the Hebrew University